02 Dec 2015

Auxiliis Partners with KinderPharm LLC

Auxiliis Partners with KinderPharm LLC  to Provide Global Access for Paediatric Drug Development and Patients AMSTERDAM – December 1, 2015 – Auxiliis has partnered with KinderPharm LLC, a US-based company focusing exclusively on paediatric drug development.  KinderPharm offers a “Single-Point-of-Accountability” model for formulation development, paediatric PK/PD analysis, paediatric dose prediction,...
+
05 Nov 2015

News update: Neurology

In this edition of our newsletter we focus on Neurology. Please review some of the latest develpments and have a look at our selection of  industry news. Does medical marijuana improve seizure control in children with epilepsy? Updated synopsis on Infantile Spasms The issue of consent in paediatric clinical trials Improved attention in children with ADHD Eisai launch book on childhood...
+
27 Jul 2015

News update: Vaccines

In this edition of our newsletter we focus on Vaccines. Please review some of the latest develpments and have a look at our selection of  industry news. The rise of Systems Vaccinology LAMP-Vax Technology to revolutionize vaccine development? The latest FDA guidance on paediatric HIV vaccine development Pfizer to acquire two GSK vaccines GSK to create a new vaccine hub check out our newsletter...
+
14 Apr 2015

News update: Pulmonology

In this edition of our newsletter we focus on Pulmonology. Please review some of the latest develpments and have a look at our selection of  industry news. Respiratory Syncytial Virus (RSV) on target for drug development The impact of Duchenne Muscolar Dystrophy on pulmonary function Cystic Fibrosis treatment: the globalization of drug development and the role of the European Medicines Agency check...
+
31 Mar 2015

New developments in pediatric oncology, advancing Hope Act

The US Food and Drug Administration (FDA) has approved earlier on 10 March an innovative treatment for high-risk neuroblastoma, a cancer that originates from immature nerve cells and occurs primarily in children and adolescents. Unitixin is the name of the new drug, marketed by United Pharmaceuticals Inc. It is an antibody that will be used in combination with other treatment modalities such as standard...
+
18 Dec 2014

News update: Oncology

In this edition of our newsletter we focus on Oncology. Please review some of the latest develpments and have a look at our selection of  industry news. Paediatric Oncology stakeholders are working together to define drug development strategy New initiative in Germany to profile childhood cancer at relapse and identify possible treatment routes New publication on pediatric oncology trials’ bias check...
+
15 Oct 2014

Auxiliis raises EUR 1.3 million to further advance paediatric clinical development

Press release 15 October 2014 Amsterdam, The Netherlands / Budapest, Hungary – Auxiliis, a full-service contract research organisation (CRO) dedicated exclusively to paediatric clinical trials, has raised EUR 1.3 million from Alliance Jura Hongrie, a Budapest-based venture capital fund. The EUR 1.3 million investment – that is expected to reach a total of EUR 2.0 million by the end of this year – will be...
+
15 Mar 2014

Auxiliis initiating 1st Pediatric Drug Development Conference

The two day conference (28 - 29 October 2014), initiated by Auxiliis, will feature presentations from academia, regulatory authorities, pharmaceutical industry, and contract research organisations. The awareness of the value of new medicines for children and clinical research with children has increased over the past decades, partially as a result of US and EU legislation. However, Paediatric clinical practice...
+